Worth Attention plasmacytoma Lenalidomide–dexamethasone plus RT linked to higher 10-year PFS in solitary plasmacytoma Ten-year progression-free survival reached 71.8% with combined treatment versus 26.7% with radiotherapy alone in this nonrandomized cohort. RadOncToday · 30 Oct 2026 ·2 min read